Reduced perioperative blood loss in children undergoing craniosynostosis surgery using prolonged tranexamic acid

Christian Fenger-Eriksen1, Alexander D'Amore Lindholm1, Sven Erik Nørholt2

  • 1Department of Anaesthesiology, Aarhus University Hospital, Denmark.

Insights

Combined tranexamic acid (TXA) treatment significantly reduced blood loss and transfusion needs in children undergoing craniosynostosis surgery. This approach improved clot stability, offering a potential method to minimize blood loss.

Area of Science:

  • Pediatric Surgery
  • Anesthesiology
  • Hematology

Background:

  • Tranexamic acid (TXA) is known to reduce intraoperative blood loss in pediatric craniosynostosis surgery.
  • Further reduction in postoperative blood loss could minimize exposure to allogeneic blood products.

Purpose of the Study:

  • To investigate the efficacy of combined intraoperative and postoperative TXA in reducing postoperative blood loss in pediatric craniosynostosis surgery.

Main Methods:

  • A randomized controlled trial involving 30 children undergoing craniosynostosis surgery.
  • Participants received either combined intra- and postoperative TXA or a placebo.
  • Primary endpoint was postoperative blood loss; secondary endpoints included total blood loss, transfusion requirements, and clot stability.

Main Results:

  • TXA significantly reduced postoperative blood loss by 18 ml/kg and total blood loss from 52 ml/kg to 28 ml/kg (P<0.001).
  • Transfusions of red blood cells (RBCs) and fresh frozen plasma (FFP) were significantly reduced in the TXA group.
  • Clot stability, assessed by tissue plasminogen activator-stimulated clot lysis assay, was significantly higher in the TXA group (P<0.001).

Conclusions:

  • Combined intra- and postoperative TXA effectively reduces both postoperative and overall blood loss in pediatric craniosynostosis surgery.
  • The treatment also decreases the need for blood transfusions.
  • Enhanced clot stability is a likely mechanism contributing to the observed reduction in blood loss.
Abstract

Related Concept Videos

Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
372
Adaptations that Reduce Water Loss01:57

Adaptations that Reduce Water Loss

Though evaporation from plant leaves drives transpiration, it also results in loss of water. Because water is critical for photosynthetic reactions and other cellular processes, evolutionary pressures on plants in different environments have driven the acquisition of adaptations that reduce water loss.
28.0K
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives01:35

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives

Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.6K
Line Loss01:10

Line Loss

The different configurations of source-load connections include wye (star) and delta connections. The relationship between line and phase voltages and currents varies depending on the configuration. When the source is supplying power, it is transmitted through the wires to the load, and during this transmission, some power is absorbed by the wires, leading to line loss.
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
535
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K